The US study shows employers' willingness to cover anti-addiction medication despite cost concerns

The US study shows employers' willingness to cover anti-addiction medication despite cost concerns

A new study aimed at understanding U.S. employers' and employees' perceptions of obesity management and use of anti-ad trait medicinePopulation Health Management.

Jamy Ard of Wake Forest School of Medicine and coauthors reported that both employees with obesity (EWO) and employer representatives (ER) acknowledged the impact of obesity on future health problems and perceived obesity as a disease. Both groups adopted the leading health care provider and the most effective approach to maintaining weight loss.

“More than two-thirds (68.6%) of ERs expressed a willingness to reconsider their anti-med coverage decisions, although the cost of drug coverage (72.5%) and the affordability of medications for employees (68.7%) were identified as barriers,” investigators said.

“Evidence demonstrates the benefits of evidence-based obesity, direct/indirect cost reductions, and the impact of obesity can address barriers to obesity coverage and improve obesity care and workforce outcomes,” the investigators concluded.

“Dr Jamy ARD and colleagues from academia, the public sector and the private sector have provided us with cutting-edge data on the burden of obesity in our countryPopulation Health Managementand Dean Emeritus and Dr. Raymond C. and Doris N. Grandon Professor, Jefferson College of Population Health, Philadelphia, PA.

Sources: